Skip to main content

Table 1 Comparison of major clinico-pathological factors between NSCLC patients with or without bone metastasis

From: Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer

Characteristics Bone metastasis (n = 45)n (%) Non-bone metastasis (n = 60)n (%) P value
Gender
Male 28 (62.2) 37 (61.7) 0.954
Female 17 (37.8) 23 (38.3)  
Age (mean ± SD) (yr.) 55.8 ± 12.1 57.4 ± 7.2 0.398
Histopathology
 Adenocarcinoma 39 (86.7) 50 (83.5) 0.567
 Non-adenocarcinoma 6 (13.3) 10 (16.7)  
Stage
 IIIa 33 (73.3) 53 (86.7) 0.048
IIIb 12 (26.7) 7 (13.3)  
Adjuvant chemotherapy
Yes 30 (66.7) 46 (76.7) 0.828
No 15 (33.3) 14 (23.3)